Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06340152 · ClinicalTrials.gov registry record
Multi-Omics for Maternal Health After Preeclampsia
A clinical trial of Preeclampsia and Pregnancy Induced Hypertension, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- 1,100
- Enrollment target
- 1
- Study location
NCT06340152: Recruiting study of Preeclampsia and Pregnancy Induced Hypertension, sponsored by University of California, San Diego.
NCT06340152 is a study of Preeclampsia and Pregnancy Induced Hypertension that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 1,100 participants, roughly in line with the 1,103-participant average among 48 other Preeclampsia trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06340152, a study of Preeclampsia and Pregnancy Induced Hypertension, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- 1,100 participants
- Enrollment target
- 1
- Study location
Study Summary
To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.
Conditions Studied
Study Locations (1)
California
- University of California, San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2023-12-20 |
| Est. Completion | 2028-12 |
What NCT06340152 shows while recruiting
NCT06340152 is an observational study that tracks outcomes without assigning an intervention. Its 1,100 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,103-participant average among 48 other Preeclampsia trials with a reported enrollment target.
The record links to 2 conditions, with Preeclampsia appearing as the primary indexed condition, and to 0 interventions.
NCT06340152 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06340152 about?
NCT06340152 is a clinical study titled "Multi-Omics for Maternal Health After Preeclampsia". To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.
What is the current status of trial NCT06340152?
This trial is currently recruiting. The enrollment target is 1,100 participants. The study started on 2023-12-20. Estimated completion is 2028-12.
What conditions does trial NCT06340152 study?
This clinical trial studies the following conditions: Preeclampsia, Pregnancy Induced Hypertension.
Who is sponsoring clinical trial NCT06340152?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06340152 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06340152's enrollment target sits among peer trials
1,100 6th of 48 higher than 43 of 48 other Preeclampsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preeclampsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
RECRUITING · Phase 2
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Daily Aspirin Treatment After Preeclampsia
RECRUITING · Early Phase 1
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Exosome Cargo From Preeclampsia Patients
RECRUITING
-
Prenatal Aspirin and Postpartum Vascular Function
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI